Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Development and evaluation of a modified method for the in vivo labeling of human erythrocytes with technetium-99m

Thesis/Dissertation ·
OSTI ID:6147703
Labeling red blood cells with Tc-99m by the standard in vivo method results in significant extravascular radioactivity, which negatively affects the quality of blood pool images. One explanation for this distribution is that technetium-99m is incorporated into red blood cells in vivo over several minutes thus allowing Tc-99m pertechnetate to distribute to the extracellular fluid during the first few minutes after injection. To test this hypothesis, serial blood samples were collected from patients during the in vivo labeling procedure using stannous DTPA as a quenching agent for the labeling reaction. The results indicated that labeling proceeds over several minutes reaching 90% at 4 minutes after technetium-99m injection. In this modified method, in vivo tinned red blood cells are withdrawn into a syringe containing technetium-99m pertechnetate and allowed to incubate for ten minutes before reinjection. At this time, 90% of the Tc-99m is firmly bound to the red blood cells. The results show that the incorporation of technetium-99m into pre-tinned red blood cells in vivo and in vitro is a time-dependent reaction with increased rate and extent of labeling occurring at 37/sup 0/C and with increasing hematocrit. Increased levels of stannous ion and the presence of plasma result in decreased labeling efficiency. The volume of whole blood, activity of Tc-99m and patient condition do not affect labelling efficiency. The interaction between hemoglobin and Tc-99m is rapid and complete.
Research Organization:
Massachusetts Coll. of Pharmacy and Allied Health Sciences, Boston (USA)
OSTI ID:
6147703
Country of Publication:
United States
Language:
English